Back to Bills
HOUSE-BILL 1262119th Congress

HOUSE-BILL 1262: H.R.1262 - Mikaela Naylon Give Kids a Chance Act

Introduced: February 12, 2025
Status: Passed House
supported

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 1262 aims to enhance the research and development of pediatric cancer treatments, specifically targeting children with cancer to ensure that drugs are adequately studied and approved for their use. The legislation addresses major themes such as healthcare access, pharmaceutical regulation, and public health safety. Key provisions include requirements for pediatric drug studies, the extension of priority review vouchers for rare pediatric diseases, and increased transparency in drug applications. Implementation will require regulatory bodies to establish protocols for pediatric studies and ensure compliance with new transparency measures. The potential impacts include improved health outcomes for children with cancer, greater availability of effective treatments, and a strengthened commitment to protecting vulnerable populations' health rights.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill has significant positive implications for individual rights, particularly for children diagnosed with cancer. By mandating research and development of pediatric treatments, it aims to ensure that vulnerable populations receive the necessary medical attention tailored to their specific needs.

Key Individual Rights

  • Right to Health Care
  • Equal Protection under the Law
  • Personal Autonomy

Constitutional Provisions

  • Fourteenth Amendment - Equal Protection Clause
  • Fourteenth Amendment - Due Process Clause

Potential Constitutional Challenges

While the bill is designed to enhance health care access, there is a risk that its implementation could inadvertently lead to disparities based on demographic factors such as race, socioeconomic status, or geographic location. This could raise concerns under the Equal Protection Clause if certain groups are disproportionately affected.

Summary

HOUSE-BILL 1262 represents a proactive approach to improving health care for children with cancer, supporting their right to informed medical care. It emphasizes the need for equitable access to treatments, which aligns with constitutional protections. However, careful monitoring is necessary to ensure that the bill does not create unintended disparities in health care access among different demographic groups.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 1262 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

February 12, 2025

Bill Introduced

Current

Passed House

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat